CD274 and cancer: Here are some potential combination strategies:Immune Checkpoint Inhibitors: Immune checkpoint inhibitors, such as antibodies targeting PD-1/PD-L1 or CTLA-4, have shown promise in enhancing immune responses against cancer cells.